Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new revision label (v3.6.5) replacing the previous v3.6.4, indicating a new release of the page content or styling.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, representing a small backend/documentation update rather than a user-facing content change.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page shows a revision tag update from v3.6.2 to v3.6.3, indicating a new build or patch applied to the study details display.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This indicates a minor metadata update to the page and does not change the study details presented.SummaryDifference0.0%

- Check72 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating enrollment has ended. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the revision label changed to v3.6.0.SummaryDifference0.4%

- Check79 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's template or metadata rather than content changes. No substantive study information appears to be affected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.